Company intelligence / Profile preview
Athos Therapeutics
Torrance / Los Angeles area, California, United Statesathostx.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Athos Therapeutics has completed a successful Phase I trial of its lead asset ATH‑063, an oral small molecule G9A inhibitor for inflammatory bowel disease. The trial demonstrated favorable safety, pharmacokinetics, no serious adverse events or dose-limiting toxicities, and selective expansion of regulatory T cells consistent with the predicted mechanism of action from their AI² computational engine. The company has multiple additional programs in preclinical or discovery stages targeting autoimmune diseases and cancer.
- Therapeutic areas
- GastroenterologyRheumatologyImmunologyEndocrinologyDermatologyOtherOncology
- Modalities
- Small molecules
- Industry
- Biotech
02
Drug pipeline
8 assets7 more assets in the full pipeline.
03
Partnerships
Not explicitly listed; however, they have collaborations with major hospital systems such as Cleveland Clinic, Crohn’s & Colitis Foundation, Lahey Hospital & Medical Center via data/sample access.
Beyond the preview
Go deeper on Athos Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Athos Therapeutics.